The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 04, 2025
Filed:
Oct. 12, 2022
Applicant:
Oxalurx, Inc., St. Louis, MO (US);
Inventors:
Ayman Kabakibi, San Diego, CA (US);
Mehmet Kahraman, La Jolla, CA (US);
Michael Clare, Skokie, IL (US);
Thomas Leedom, Escondido, CA (US);
Assignee:
OxaluRx, Inc., Saint Louis, MO (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); A61K 31/4192 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/497 (2006.01); A61K 31/501 (2006.01); C07D 249/04 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 31/4192 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/497 (2013.01); A61K 31/501 (2013.01); C07D 249/04 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01);
Abstract
Disclosed herein are compounds and compositions for modulating glycolate oxidase, useful for treating oxalate-related diseases, such as hyperoxaluria, where modulating glycolate oxidase is expected to be therapeutic to a patent in need thereof. Methods of modulating glycolate oxidase activity in a human or animal subject are also provided.